Trust Prolytix to provide data that are not only accurate but also optimally resolved, driving greater confidence in your excipient analysis results. Download our resource to learn more.
Revolutionizing Polysorbate Analysis: Prolytix’s Comprehensive, Cutting-Edge Services Read More »
Developing novel biotherapeutics that are safe and effective requires a strategic and collaborative approach. At Prolytix, we offer integrated bioanalytical services that span your product’s entire life cycle, providing you with critical insights for confident decisions. Download our fact sheet to learn more.
Integrated Bioanalytical Services to Drive Your Biotherapeutic Development Read More »
De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Download our white paper to learn what you need to know with regard to new biomarker assay development.
WHITE PAPER: IMPROVEMENTS TO PS80 DETECTION IN DRUG PRODUCT FORMULATIONS This technical white paper details Prolytix’s mixed-mode high-performance liquid chromatography method for the determination of polysorbates, such as PS80. The method offers notable improvements over a conventional reverse-phase HPLC method. The paper includes discussion of: Download now.
Improvements to PS80 Detection in Drug Product Formulations Read More »
Realizing the therapies of the future requires ongoing innovation and measurable advancements in biotherapeutic development. In this blog, we look at three essential ways that this is currently being achieved: A commitment to the highest levels of excellence in science, as well as prioritizing collaboration between our scientists and the clients that come to Prolytix
Top Factors Driving Advancements in Biotherapeutic Development Read More »
Choosing the right bioanalytical CRO partner is one of the most important decisions you’ll make in the development of your drug. For comprehensive characterization that enables you to make your biggest decisions with confidence, go with the pro — Prolytix. Download Now:
High-Resolution Mass Spectrometry + HCP Solutions: The Prolytix Difference Read More »
Picking a partner for your biotherapeutic program is one of the most crucial decisions you’ll make. When you partner with a CRO, you’re melding outside expertise and resources with your internal knowledge base to expand and accelerate your problem-solving capabilities. This is a tremendous gain, but it’s important to remember that you are the client,
Choosing the appropriate analytical and bioanalytical CRO partner is critical to the success of your biotherapeutic drug development program. Selecting the wrong partner could delay timelines and increase costs, putting your innovation at risk. For large molecule and protein chemistry expertise to accelerate your drug development, go with the pro — Prolytix. Download Now:
Process Development, Analytical Development, & GMP Testing and Release Services Read More »
Explore our work with a highly efficient method of plasma fractionation that could revolutionize IVIG production in this process talk by Matthew Whelihan, Ph.D. Download Now:
Using mass spectrometry to identify and quantify HCPs enables a more rational development of robust purification processes.
